Action required: Please refresh your browser
We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.
More details about this topic are available here »
HDA Statement On Attorneys General Opioid Investigations | ||
By: PR Newswire Association LLC. - 19 Sep 2017 | Back to overview list |
|
ARLINGTON, Va., Sept. 19, 2017 /PRNewswire-USNewswire/ -- Following today's announcement on investigations regarding the opioid epidemic, John M. Gray, President and CEO of the Healthcare Distribution Alliance (HDA), released the following statement: "Pharmaceutical distributors welcome the opportunity to have a full discussion about how, and why, opioids have been overprescribed and how our industry can be positive contributors to addressing this public health crisis and its root causes." "While distributors play a vital role as logistics companies, to suggest that they are responsible for the volume of opioids prescribed lacks a fundamental understanding of how the supply chain works and is regulated. Distributors have no ability to influence what prescriptions are written. The fact is that distributors don't make medicines, market medicines, prescribe medicines or dispense them to consumers. Our role is to deliver medicines safely, securely and efficiently from manufacturers to pharmacies, hospitals and other healthcare institutions based on prescriptions written by licensed prescribers." Background:
About the Healthcare Distribution Alliance View original content:http://www.prnewswire.com/news-releases/hda-statement-on-attorneys-general-opioid-investigations-300522358.html SOURCE Healthcare Distribution Alliance |
||
|
||
Copyright 2017 PR Newswire Association LLC. | Back to overview list |